Finally, we show that HMGB1-ΔC retains the capacity of the full-length protein to perturb the metabolism of cancer cells even if the capacity of the cells to circumvent oxidative phosphorylation inhibition might determine their cellular outcome. Here, HMGB1 is linked to cancer.